Current Treatment Modalities Associated With Glioblastoma and Its Merits and Demerits
- 5 September 2025
- book chapter
- Published by IGI Global Scientific Publishing
- p. 1-32
Abstract
Glioblastoma multiforme (GBM) is an aggressive primary brain tumor marked by rapid progression, diffuse infiltration, and poor prognosis. Conventional treatments—surgical resection, radiotherapy, and temozolomide chemotherapy—offer limited success due to intratumoral heterogeneity, the blood-brain barrier (BBB), glioma stem-like cells. Novel immunotherapeutic strategies, including immune checkpoint inhibitors, CAR T and CAR-NK cells, dendritic cell vaccines, and oncolytic virotherapy, are under investigation to improve immune-mediated tumor eradication. Tumor-treating fields (TTFs) and targeted molecular therapies show additional promise. This chapter explores the molecular and metabolic landscape of GBM, reviews current and emerging therapies, and underscores the urgent need for integrated, personalized treatment strategies to improve patient outcomes.Keywords
This publication has 79 references indexed in Scilit:
- Personalized Medicine and Therapeutics2024
- Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed GlioblastomaJAMA Oncology, 2020
- Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic featuresActa Neuropathologica, 2020
- Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaActa Neuropathologica, 2018
- Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastasesCochrane Database of Systematic Reviews, 2017
- Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical resultsActa Neurochirurgica, 2016
- Fluorescence guided resection and glioblastoma in 2015: A reviewLasers in Surgery and Medicine, 2015
- Recent advances in the molecular understanding of glioblastomaJournal of Neuro-Oncology, 2012
- Molecular diagnostics of gliomas: state of the artActa Neuropathologica, 2010
- ALA and Photofrin® Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trialLasers in Medical Science, 2007